title: [Ataxic Guillain-Barré syndrome with delayed facial diplegia].
abstract: We described a patient with ataxic Guillain-Barré syndrome who subsequently developed facial diplegia. A 38-year-old man developed ataxia, distal limb paresthesias, mild dysphagia, urinary retention and orthostatic hypotension a week after an episode of laryngitis. He had high titers of serum anti-GQ1b, anti-GD1b, anti-GM1b, anti-GT1a, and anti-GD1a IgG antibodies during the acute phase. Although the initial symptoms markedly improved by intravenous immunoglobulin therapy, asymmetric facial diplegia subsequently occurred and remained longer than ataxia. Similar course of facial nerve palsy has been reported in patients with Fisher syndrome. Common pathophysiological mechanism may function in the development of delayed facial diplegia in Fisher syndrome and ataxic Guillain-Barre syndrome.
authors.affiliation: Department of Neurology, Baba Memorial Hospital.
authors.forename: Masahiko
authors.initials: M
authors.lastname: Atsumi
authors.forename: Masataka
authors.initials: M
authors.lastname: Kitaguchi
authors.forename: Yuko
authors.initials: Y
authors.lastname: Chimoto
authors.forename: Shogo
authors.initials: S
authors.lastname: Nishikawa
authors.forename: Haruyuki
authors.initials: H
authors.lastname: Mineta
authors.forename: Yoshikuni
authors.initials: Y
authors.lastname: Nakasaka
authors.forename: Hisashi
authors.initials: H
authors.lastname: Tanaka
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Susuki
mesh_terms: D000328:Adult; D001259:Ataxia / Q000150:complications*; D005158:Facial Paralysis / Q000209:etiology*; D020275:Guillain-Barre Syndrome / Q000150:complications* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D019846:Miller Fisher Syndrome; D010292:Paresthesia / Q000209:etiology
chemical_list: D016756:Immunoglobulins, Intravenous